Eledon Pharmaceuticals, Inc. (ELDN) Tops Q4 EPS by 4c

Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) reported Q4 EPS of ($0.32), $0.04 better than the analyst estimate of ($0.36).

For earnings history and earnings-related data on Eledon Pharmaceuticals, Inc. (ELDN) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• GE Vernova (GEV) PT Raised to $1,185 at Jefferies
• Premarket movers: Oracle surges on AI growth, ACV auctions jumps on $1.9B deal